Homeopathic Claims Pose Continuing FTC/FDA Regulatory Conflict
FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s oversight of the category.